The industry has been given just a few days to review and provide feedback on guidelines for the new 25 per cent statutory price cut that many believe do not match the intent of the Medicines Australia strategic agreement.

Latest Video
New Stories
-
Is New Zealand leading Australia on AI in medicines evaluation and assessment
August 18, 2025 - - Latest News -
Lilly launches new initiative with Monash University to improve gaps in obesity management
August 18, 2025 - - Latest News -
Should we keep these processes separate until the minister has determined the outcome?
August 18, 2025 - - Latest News -
Novartis unveils new solution to simplify HCP access to private prescriptions
August 18, 2025 - - Latest News -
A journey to complexity - the PBAC’s decade-long language shift on pricing and access
August 18, 2025 - - Latest News -
Novo Nordisk launches global-first Marie Krogh Young Women in Science Prize in Australia
August 18, 2025 - - Latest News -
BeiGene launches its new name and brand identity in Australia and New Zealand
August 18, 2025 - - Latest News